Inventor
SCHULZE VOLKER
DE27 patents
⚠️ This page may combine multiple inventors who share the name “SCHULZE VOLKER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
Bayer Pharma AG
10 patentsUS9409889B2Aug 9, 2016
Amino-substituted imidazopyridazines
Bayer Pharma AG3 citations72
US10428063B2Oct 1, 2019
4H-pyrrolo[3,2-C]pyridin-4-one derivatives
Bayer Pharma AG3 citations69
US9670202B2Jun 6, 2017
Substituted triazolopyridines
Bayer Pharma AG2 citations62
US9388177B2Jul 12, 2016
Method for preparing substituted triazolopyridines
Bayer Pharma AG0 citations52
US10894784B2Jan 19, 2021
Heteroarylbenzimidazole compounds
Bayer Pharma AG0 citations48
US10214545B2Feb 26, 2019
Amido-substituted imidazopyridazines useful in the treatment of hyper-proliferative and/or angiogenesis disorders
Bayer Pharma AG0 citations41
US9783543B2Oct 10, 2017
Aminoimidazopyridazines
Bayer Pharma AG0 citations41
US9745304B2Aug 29, 2017
Amidoimidazopyridazines as MKNK-1 kinase inhibitors
Bayer Pharma AG0 citations41
US10428044B2Oct 1, 2019
3-amino-1,5,6,7-tetrahydro-4H-indol-4-ones
Bayer Pharma AG0 citations39
US9586958B2Mar 7, 2017
Prodrug derivatives of substituted triazolopyridines
Bayer Pharma AG0 citations38
BAYER IP GMBH
5 patentsUS10266548B2Apr 23, 2019
Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases
BAYER IP GMBH2 citations71
US10604532B2Mar 31, 2020
Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperproliferative diseases
BAYER IP GMBH0 citations50
US9663510B2May 30, 2017
Substituted triazolopyridines and their use as TTK inhibitors
BAYER IP GMBH1 citations50
US9777004B2Oct 3, 2017
Amino-substituted imidazopyridazines
BAYER IP GMBH0 citations41
US9643974B2May 9, 2017
Amino-substituted imidazopyridazines
BAYER IP GMBH0 citations41
BAYER AG
3 patentsUS11339157B1May 24, 2022
4H-pyrrolo[3,2-c]pyridin-4-one derivatives
BAYER AG2 citations69
US12227501B2Feb 18, 2025
3-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one as CSNK1 inhibitors
BAYER AG1 citations58
US12565496B2Mar 3, 2026
Substituted 1H-pyrrolo[3,2-b]pyridine compounds and methods of use thereof
BAYER AG0 citations43